News Extra [these Stories Appear Only On The Web]
Drug company chairman calls for trial period to evaluate drugs
BMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7223.1456e (Published 04 December 1999) Cite this as: BMJ 1999;319:1456
- Roger Dobson
- Abergavenny
Demands that the pharmaceutical industry should show “value in use” at the time of a drug's launch are misguided, GlaxoWellcome's chairman, Sir Richard Sykes, warned this week. He suggested that a new way forward would be a system where drugs could be value tested while they were on the market for a …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.